Search tips
Search criteria 


Logo of envhperEnvironmental Health PerspectivesBrowse ArticlesAbout EHPGeneral InformationAuthorsMediaProgramsPartnerships
Environ Health Perspect. 2003 September; 111(12): 1485–1489.
PMCID: PMC1241651
Research Article

Neuroendocrine effects of perfluorooctane sulfonate in rats.


Perfluorooctane sulfonate (PFOS) is a degradation product of sulfonyl-based fluorochemicals that are used extensively in industrial and household applications. Humans and wildlife are exposed to this class of compounds from several sources. Toxicity tests in rodents have raised concerns about potential developmental, reproductive, and systemic effects of PFOS. However, the effect of PFOS on the neuroendocrine system has not been investigated thus far. In this study, adult female rats were injected intraperitoneally with 0, 1, or 10 mg PFOS/kg body weight (BW) for 2 weeks. Food and water intake, BW, and estrous cycles were monitored daily. At the end of treatment, PFOS levels in tissues were measured by high-performance liquid chromatography (HPLC) interfaced with electrospray mass spectrometry. Changes in brain monoamines were measured by HPLC with electrochemical detection, and serum corticosterone and leptin were monitored using radioimmunoassay. Treatment with PFOS produced a dose-dependent accumulation of this chemical in various body tissues, including the brain. PFOS exposure decreased food intake and BW in a dose-dependent manner. Treatment with PFOS affected estrous cyclicity and increased serum corticosterone levels while decreasing serum leptin concentrations. PFOS treatment also increased norepinephrine concentrations in the paraventricular nucleus of the hypothalamus. These results indicate that exposure to PFOS can affect the neuroendocrine system in rats.

Full Text

The Full Text of this article is available as a PDF (147K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Ahima RS. Leptin and the neuroendocrinology of fasting. Front Horm Res. 2000;26:42–56. [PubMed]
  • Borges T, Robertson LW, Peterson RE, Glauert HP. Dose-related effects of perfluorodecanoic acid on growth, feed intake and hepatic peroxisomal beta-oxidation. Arch Toxicol. 1992;66(1):18–22. [PubMed]
  • Case MT, York RG, Christian MS. Rat and rabbit oral developmental toxicology studies with two perfluorinated compounds. Int J Toxicol. 2001 Mar-Apr;20(2):101–109. [PubMed]
  • Francis J, MohanKumar SM, MohanKumar PS. Correlations of norepinephrine release in the paraventricular nucleus with plasma corticosterone and leptin after systemic lipopolysaccharide: blockade by soluble IL-1 receptor. Brain Res. 2000 Jun 9;867(1-2):180–187. [PubMed]
  • Giesy JP, Kannan K. Global distribution of perfluorooctane sulfonate in wildlife. Environ Sci Technol. 2001 Apr 1;35(7):1339–1342. [PubMed]
  • Hansen KJ, Clemen LA, Ellefson ME, Johnson HO. Compound-specific, quantitative characterization of organic fluorochemicals in biological matrices. Environ Sci Technol. 2001 Feb 15;35(4):766–770. [PubMed]
  • Haughom B, Spydevold O. The mechanism underlying the hypolipemic effect of perfluorooctanoic acid (PFOA), perfluorooctane sulphonic acid (PFOSA) and clofibric acid. Biochim Biophys Acta. 1992 Sep 22;1128(1):65–72. [PubMed]
  • Kannan K, Franson JC, Bowerman WW, Hansen KJ, Jones PD, Giesy JP. Perfluorooctane sulfonate in fish-eating water birds including bald eagles and albatrosses. Environ Sci Technol. 2001 Aug 1;35(15):3065–3070. [PubMed]
  • Kannan K, Hansen KJ, Wade TL, Giesy JP. Perfluorooctane sulfonate in oysters, Crassostrea virginica, from the Gulf of Mexico and the Chesapeake Bay, USA. Arch Environ Contam Toxicol. 2002 Apr;42(3):313–318. [PubMed]
  • Kannan K, Koistinen J, Beckmen K, Evans T, Gorzelany JF, Hansen KJ, Jones PD, Helle E, Nyman M, Giesy JP. Accumulation of perfluorooctane sulfonate in marine mammals. Environ Sci Technol. 2001 Apr 15;35(8):1593–1598. [PubMed]
  • Luebker Deanna J, Hansen Kris J, Bass Nathan M, Butenhoff John L, Seacat Andrew M. Interactions of fluorochemicals with rat liver fatty acid-binding protein. Toxicology. 2002 Jul 15;176(3):175–185. [PubMed]
  • Mohankumar PS, Thyagarajan S, Quadri SK. Correlations of catecholamine release in the medial preoptic area with proestrous surges of luteinizing hormone and prolactin: effects of aging. Endocrinology. 1994 Jul;135(1):119–126. [PubMed]
  • MohanKumar SM, MohanKumar PS, Quadri SK. Specificity of interleukin-1beta-induced changes in monoamine concentrations in hypothalamic nuclei: blockade by interleukin-1 receptor antagonist. Brain Res Bull. 1998 Sep 1;47(1):29–34. [PubMed]
  • Olsen GW, Burris JM, Burlew MM, Mandel JH. Plasma cholecystokinin and hepatic enzymes, cholesterol and lipoproteins in ammonium perfluorooctanoate production workers. Drug Chem Toxicol. 2000 Nov;23(4):603–620. [PubMed]
  • Olsen GW, Burris JM, Mandel JH, Zobel LR. Serum perfluorooctane sulfonate and hepatic and lipid clinical chemistry tests in fluorochemical production employees. J Occup Environ Med. 1999 Sep;41(9):799–806. [PubMed]
  • Palkovits M. Isolated removal of hypothalamic or other brain nuclei of the rat. Brain Res. 1973 Sep 14;59:449–450. [PubMed]
  • Pastoor TP, Lee KP, Perri MA, Gillies PJ. Biochemical and morphological studies of ammonium perfluorooctanoate-induced hepatomegaly and peroxisome proliferation. Exp Mol Pathol. 1987 Aug;47(1):98–109. [PubMed]
  • Seacat Andrew M, Thomford Peter J, Hansen Kris J, Olsen Geary W, Case Marvin T, Butenhoff John L. Subchronic toxicity studies on perfluorooctanesulfonate potassium salt in cynomolgus monkeys. Toxicol Sci. 2002 Jul;68(1):249–264. [PubMed]
  • Starkov AA, Wallace KB. Structural determinants of fluorochemical-induced mitochondrial dysfunction. Toxicol Sci. 2002 Apr;66(2):244–252. [PubMed]
  • Szafarczyk A, Guillaume V, Conte-Devolx B, Alonso G, Malaval F, Pares-Herbuté N, Oliver C, Assenmacher I. Central catecholaminergic system stimulates secretion of CRH at different sites. Am J Physiol. 1988 Oct;255(4 Pt 1):E463–E468. [PubMed]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Science